XAIR
Beyond Air IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$5.53M
P/E Ratio
—
EPS
$-4.47
Beta
0.53
52W High
$5.84
52W Low
$0.43
50-Day MA
$0.74
200-Day MA
$1.61
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Beyond Air Inc
Beyond Air, Inc., a clinical-stage biopharmaceutical and medical device company, develops nitric oxide (NO) generators and delivery systems. The company is headquartered in Garden City, New York.
Fundamentals
| Revenue (TTM) | $6.92M |
| Gross Profit (TTM) | 126,000 |
| EBITDA | $-25.79M |
| Operating Margin | -300.60% |
| Return on Equity | -240.20% |
| Return on Assets | -51.20% |
| Revenue/Share (TTM) | $1.13 |
| Book Value | $0.96 |
| Price-to-Book | 0.68 |
| Price-to-Sales (TTM) | 0.80 |
| EV/Revenue | 2.516 |
| EV/EBITDA | -4.23 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 104.70% |
| Shares Outstanding | $10.53M |
| Float | $9.41M |
| % Insiders | 4.40% |
| % Institutions | 15.43% |
Historical Volatility
HV 10-Day
123.62%
HV 20-Day
142.09%
HV 30-Day
122.49%
HV 60-Day
97.29%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($8.67 target)
1
Strong Buy2
Buy1
HoldData last updated: 5/1/2026